STOCK TITAN

Yatsen CEO on Science-Backed Beauty, Turnaround Strategy, and Global Positioning

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags

Yatsen Holding (NYSE: YSG) CEO David Huang shared insights on the company's evolution from a trend-focused startup to a global beauty innovation leader. The company, founded in 2016, has expanded to 11 brands across mass, masstige, and premium segments, including notable acquisitions like Galenic and EVE LOM.

Key highlights include a strategic shift towards science-backed beauty, with over $80 million invested in R&D, 240+ patent filings, and publications in prestigious journals. The company allocates 3% of revenue to R&D, positioning itself among global leaders in beauty innovation spending. Yatsen has successfully resumed profitable growth following its transformation, completed a $200 million share buyback, and maintains a strong domestic supply chain to minimize global trade disruptions.

Operating in China's RMB 400 billion beauty market, Yatsen focuses on high-value, science-driven products like the Biolip Essence Lipstick, while exploring new frontiers in neuroscience applications for skincare.

Loading...
Loading translation...

Positive

  • Resumed profitable growth after strategic transformation
  • Completed $200 million share buyback program
  • Strong R&D investment with 3% of revenue allocation
  • Filed 240+ patents and published in prestigious scientific journals
  • Expanded to 11 brands across different market segments
  • exposure to global supply chain disruptions due to domestic sourcing

Negative

  • Stock price remains below IPO levels
  • Operating in highly fragmented market with single-digit market shares
  • Facing increased price sensitivity from post-COVID consumers

News Market Reaction

+1.18%
1 alert
+1.18% News Effect

On the day this news was published, YSG gained 1.18%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

SHANGHAI, April 25, 2025 /PRNewswire/ -- On a recent episode of Bloomberg's China Show, David (Jingfeng) Huang, Founder, Chairman and CEO of Yatsen Holding Ltd. (NYSE: YSG), offered a revealing look into how the Chinese beauty tech company is evolving from a trend-savvy startup into a global innovation leader.

From a growing portfolio of brands to deep investments in science and R&D, Huang positioned Yatsen as a rare hybrid—both agile and deeply rooted in long-term thinking. His message was clear: beauty is being redefined, and Yatsen intends to lead the next era.

A Vision to Build a Tech-Driven Beauty Powerhouse

Founded in 2016, Yatsen first captured attention through Perfect Diary, now a mainstream brand in China. Since then, the company has expanded to 11 brands, spanning mass, masstige, and premium tiers.

Its lineup includes France's Galenic, focused on cellular anti-aging, the sensorial British skincare brand EVE LOM, and dermatologist-backed Dr.Wu. Together, these brands reflect a deliberate strategy: address varied consumer needs with credible, differentiated propositions.

"Our vision was always to build a next-generation beauty tech company," Huang explained. "From trend-driven to science-backed, we now offer products across all major segments—what unites them is innovation."

China's Beauty Consumers: Smart, Selective, and Innovation-Hungry

The domestic beauty market in China is vast—valued at over RMB 400 billion—yet remains fragmented. Even the top players only command single-digit market shares, giving agile innovators room to grow.

Despite recent macro challenges, Huang is confident: "Chinese consumers are still highly willing to pay—as long as the product truly delivers."

That belief led to one of Yatsen's breakout hits: the Biolip Essence Lipstick. Priced similarly to global luxury brands, this hybrid product combines high-performance color with skincare benefits, including patented ingredients that stimulate collagen and reduce lip wrinkles.

"It's not just makeup. It's biotech in a lipstick," Huang said. "And the market responded—we've seen strong repurchase and loyalty."

Science-Led Premiumization: A Strategic Pivot

Yatsen's transformation goes beyond branding. In 2021, the company initiated a strategic shift: lean harder into skincare, R&D, and innovation-led premiumization. The move was both ambitious and risky, as it involved restructuring operations, reallocating capital, and riding out a tough market cycle.

"Turning around a public company isn't easy," said Huang. "But we knew where the market was going—toward science-backed, benefit-driven beauty. We invested over $80 million in R&D, filed 240+ patents, and published in top-tier journals like Nature Medicine and Science Bulletin."

He added that 3% of Yatsen's revenue is now allocated to R&D—putting the company among global leaders in innovation spend ratio in the beauty category.

Profitability Resumed, Market Confidence Growing

While Yatsen's stock price has yet to return to IPO levels, Huang emphasized the fundamentals are stronger than ever.

"Since last quarter, investor feedback has been increasingly positive. But more important than sentiment is performance—we've resumed profitable growth, with a long-term focus on value creation," he said.

The turnaround, built on disciplined brand building and product innovation, has earned Yatsen growing respect among long-term investors.

"We believe the equity market is a weighing machine over time. Our job is to do the right things—R&D, great products, strong brands—and the value will follow."

Resilience in a Volatile Global Landscape

Huang also addressed concerns around trade and supply chain disruptions, particularly in light of global tariff tensions.

While the beauty industry is highly globalized, Yatsen has insulated itself well. Most of its components and ingredients are sourced domestically, and its primary market remains mainland China.

"We're not immune, but we're well-positioned," he said. "We monitor risks—supplier stability, cross-border issues—but our current exposure is manageable. Still, we stay agile."

When asked whether cost increases from potential tariffs would be passed on to consumers, Huang pointed to the brand's focus on delivering value, not just price.

"Consumers are smart. Post-COVID, they're more price-sensitive, but they're not chasing the lowest price. They want high value—products that justify their cost."

A Different Playbook From Global Competitors

Huang believes that Yatsen's unique blend of local insight and global scientific ambition sets it apart from multinationals struggling to regain ground in China.

"We're not just following trends—we're deeply embedded in where Chinese consumer preferences are heading," he said. "Biotech, neuroscience, ingredient innovation—this is where we're betting big."

Yatsen is already seeing results from this strategy with loyal followings for products under brands like Galenic and high-performance serums featuring vitamin A and C.

In a nod to its future direction, Huang revealed that Yatsen is now exploring neuroscience applications in skincare—a niche with massive long-term potential.

Capital Strategy: Transparency, Optionality, and Growth

On the capital markets front, Huang acknowledged investor concerns around ADR delistings and so on. But Yatsen is taking a disciplined, transparent approach.

The company completed a $200 million share buyback, reinforcing confidence and alignment with shareholders.

Yatsen represents a rare blend of scale, agility, and innovation depth. With proven market traction, a science-led product pipeline, and a profitable operating model, the company is positioned to capture long-term share in a fragmented, fast-evolving industry. In terms of Yatsen's vision,  "We're not just making beauty products," Huang concluded, "We're inventing the future of beauty—and we're just getting started."

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/yatsen-ceo-on-science-backed-beauty-turnaround-strategy-and-global-positioning-302438317.html

SOURCE Yatsen Holding Limited

FAQ

What is Yatsen's (YSG) current R&D investment strategy in the beauty sector?

Yatsen invests 3% of revenue in R&D, has invested over $80 million total, filed 240+ patents, and published in journals like Nature Medicine and Science Bulletin.

How has Yatsen (YSG) transformed its business strategy since 2021?

The company shifted focus to skincare, R&D, and innovation-led premiumization, restructuring operations and reallocating capital to science-backed beauty products.

What brands are in Yatsen's (YSG) current portfolio?

Yatsen owns 11 brands across mass, masstige, and premium segments, including Perfect Diary, Galenic, EVE LOM, and Dr.Wu.

How is Yatsen (YSG) addressing global trade and supply chain risks?

The company maintains primarily domestic sourcing for components and ingredients, focusing on mainland China as its primary market to minimize exposure to global disruptions.

What recent financial actions has Yatsen (YSG) taken to boost investor confidence?

Yatsen has resumed profitable growth and completed a $200 million share buyback program to reinforce shareholder confidence.
Yatsen Hldg Ltd

NYSE:YSG

YSG Rankings

YSG Latest News

YSG Latest SEC Filings

YSG Stock Data

383.54M
61.53M
3.58%
25.85%
1.59%
Household & Personal Products
Consumer Defensive
Link
China
Guangzhou